Imaging Measures of Respiratory Health Registry
Launched by UNIVERSITY OF BRITISH COLUMBIA · Oct 29, 2021
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The Imaging Measures of Respiratory Health Registry is a study designed to gather information about lung health in both healthy individuals and those with respiratory diseases. Researchers will use advanced imaging techniques, like MRI (Magnetic Resonance Imaging), to look at how the lungs work and their structure. This study aims to create new ways to analyze lung images, which could help improve our understanding of respiratory conditions.
Anyone aged 0 to 99 years can participate, whether they have a lung condition diagnosed by a doctor or are completely healthy. To join, participants (or their guardians) will need to give their consent and should be able to follow instructions during the MRI process. It's important to note that people with certain health issues, like needing extra oxygen or having a history of claustrophobia, may not be eligible. During the study, participants can expect to undergo imaging tests and share some general health information, which will help researchers advance their knowledge of lung health.
Gender
ALL
Eligibility criteria
- • Respiratory Disease
- Inclusion Criteria:
- • 1. Physician-diagnosed lung disease - based on a diagnosis made by a treating staff physician and confirmed by the principal investigator.
- • 2. Age 0-99 years.
- • 3. Informed consent by participant, parent, or legal guardian
- • 4. In the opinion of the Investigator, the participant will likely be able to perform maneuvers to obtain technically acceptable pulmonary XeMRI images.
- Exclusion Criteria:
- • 1. Physical findings at screening that, in the opinion of the Investigator, would compromise the safety of the participant or the quality of the research data.
- • 2. Requirement of supplementary oxygen to maintain an oxygen saturation above 95%.
- • 3. Failed MRI screening form.
- • 4. History of claustrophobia.
- • 5. Known current pregnancy or lactation.
- • Healthy
- Inclusion Criteria:
- • 1. Age 0-99 years
- • 2. Informed consent by participant, parent, or legal guardian
- • 3. In the opinion of the Investigator, the participant will likely be able to perform maneuvers to obtain technically acceptable pulmonary MRI images.
- • Exclusion Criteria
- • 1. Physician-diagnosed lung disease.
- • 2. Failed MRI screening form.
- • 3. History of claustrophobia.
- • 4. Physical findings at screening that, in the opinion of the Investigator, would compromise the safety of the participant or the quality of the research data.
- • 5. Known current pregnancy or lactation.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Vancouver, British Columbia, Canada
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Jonathan Rayment, MDCM, MSc
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials